Home » Topics » BioWorld Science

BioWorld Science
RSS

Ribonucleotide reductase inhibitor 3-AP in development at Vion

May 17, 1996

AmBisome approved in India

May 17, 1996

Myotrophin up for advisory committee review

May 17, 1996

Akzo Nobel claims contraceptive vaccines

May 17, 1996

RPR, Novo Nordisk form global HRT alliance

May 17, 1996

Yamanouchi claims antidiabetic agents

May 17, 1996

RenaGel results announced at Harvard seminar

May 17, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

Schering-Plough adenosine A1 receptor ligand described for renal failure

May 17, 1996

Disappointing results attained in Recordati/SKB BPH trial

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...